A Study of RC118 in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
China
Zhongshan Hospital Affiliated to Fudan University, Shanghai, Shanghai Municipality The first affiliated hospital, zhejiang universtity school of medicine, Hangzhou, Zhejiang Last updated January 2025